Manufacturing roundup: MilliporeSigma launches new AAV platform; New IV fluid manufacturing facility is coming to central Florida
Merck KGaA’s MilliporeSigma has launched a new AAV production platform.
The platform will enable the CDMO to provide viral vector manufacturing including AAV, lentiviral, CDMO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.